We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$5.41B
AUM Growth
+$1.18B
Cap. Flow
+$984M
Cap. Flow %
18.18%
Top 10 Hldgs %
20.49%
Holding
1,162
New
152
Increased
695
Reduced
244
Closed
54

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$64.8M
2
JD icon
JD.com
JD
+$44.9M
3
MELI icon
Mercado Libre
MELI
+$40.5M
4
NTES icon
NetEase
NTES
+$38M
5
BEKE icon
KE Holdings
BEKE
+$21.5M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 33.21%
2 Technology 22.71%
3 Communication Services 13.35%
4 Financials 4.97%
5 Industrials 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RUN icon
951
Sunrun
RUN
$2.46B
$23K ﹤0.01%
382
+61
+19% +$4.24K
RYTM icon
952
Rhythm Pharmaceuticals
RYTM
$7.96B
$23K ﹤0.01%
1,110
+95
+9% +$2.75K
SNDX icon
953
Syndax Pharmaceuticals
SNDX
$1.82B
$23K ﹤0.01%
1,065
+125
+13% +$2.82K
STRO icon
954
Sutro Biopharma
STRO
$421M
$23K ﹤0.01%
102
+12
+13% +$2.85K
TD icon
955
Toronto Dominion Bank
TD
$200B
$23K ﹤0.01%
363
+242
+200% +$14.8K
Y
956
DELISTED
Alleghany Corp
Y
$23K ﹤0.01%
38
+8
+27% +$4.95K
AKRO
957
DELISTED
Akero Therapeutics
AKRO
$22K ﹤0.01%
790
-5
-0.6% -$151
ENTA icon
958
Enanta Pharmaceuticals
ENTA
$400M
$22K ﹤0.01%
460
-5
-1% -$249
MNKD icon
959
MannKind Corp
MNKD
$1.32B
$22K ﹤0.01%
5,620
+285
+5% +$1.17K
PCVX icon
960
Vaxcyte
PCVX
$8.64B
$22K ﹤0.01%
1,150
-30
-3% -$755
PRTA icon
961
Prothena Corp
PRTA
$450M
$22K ﹤0.01%
900
-15
-2% -$282
GTHX
962
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$22K ﹤0.01%
945
+70
+8% +$1.63K
RDUS
963
DELISTED
Radius Health, Inc.
RDUS
$22K ﹤0.01%
1,060
-25
-2% -$527
ADVM
964
DELISTED
Adverum Biotechnologies
ADVM
$21K ﹤0.01%
221
-3
-1% -$360
AFMD
965
DELISTED
Affimed
AFMD
$20K ﹤0.01%
261
+50
+24% +$3.25K
NBP
966
NovaBridge Biosciences American Depositary Shares
NBP
$202M
$20K ﹤0.01%
420
+60
+17% +$3.25K
OHI icon
967
Omega Healthcare
OHI
$14.7B
$20K ﹤0.01%
566
+88
+18% +$3.24K
ORIC icon
968
Oric Pharmaceuticals
ORIC
$1.4B
$20K ﹤0.01%
825
-15
-2% -$474
PASG icon
969
Passage Bio
PASG
$14.1M
$20K ﹤0.01%
60
+8
+15% +$3.42K
RGA icon
970
Reinsurance Group of America
RGA
$16.1B
$20K ﹤0.01%
166
+24
+17% +$2.85K
VNO icon
971
Vornado Realty Trust
VNO
$7.38B
$20K ﹤0.01%
451
+72
+19% +$2.98K
PETQ
972
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$20K ﹤0.01%
570
-10
-2% -$354
EPZM
973
DELISTED
Epizyme, Inc
EPZM
$20K ﹤0.01%
2,300
-30
-1% -$310
VER
974
DELISTED
VEREIT, Inc.
VER
$20K ﹤0.01%
534
+80
+18% +$2.99K
AMPH icon
975
Amphastar Pharmaceuticals
AMPH
$916M
$19K ﹤0.01%
1,070
-20
-2% -$372

Similar funds

Penserra Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Penserra Capital Management held 1,162 positions worth $5.41B, up 28% from $4.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Penserra Capital Management deployed $984M of net new capital in Q1 2021, opening 152 new positions and adding to 695 existing holdings. Its largest new stake was BlackRock Resources & Commodities Strategy Trust: 1,847,500 shares worth $16.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Futu Holdings, an estimated $21.6M trimmed.

  • Penserra Capital Management's largest Q1 2021 buy was BlackRock Resources & Commodities Strategy Trust: 1,847,500 shares worth $16.4M.
  • Penserra Capital Management added most to Alibaba in Q1 2021, an estimated $64.8M increase.
  • Penserra Capital Management's biggest Q1 2021 reduction was Futu Holdings, cutting an estimated $21.6M.
  • Penserra Capital Management fully exited abrdn Total Dynamic Dividend Fund in Q1 2021, selling an estimated $12.1M.
  • Penserra Capital Management's ten largest holdings make up 20% of its $5.41B portfolio in Q1 2021.
  • Penserra Capital Management opened 152 new positions and closed 54 in Q1 2021.
  • Penserra Capital Management's portfolio value rose 28% quarter-over-quarter to $5.41B.

Based on Penserra Capital Management's 13F filing for Q1 2021, filed 13 May 2021.